Tempo Therapeutics Inc — National Science Foundation SBIR Phase I: PT
Tempo Therapeutics Inc — SBIR Phase I award from National Science Foundation.
- Amount
- $255,998
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- PT
- NAICS
- —
- Place of performance
- CA
- Period
- 2020-09-01 → 2021-04-30
Description
The broader impact of this Small Business Innovation Research (SBIR) Phase I project will advance a new vaccine delivery technology against new emerging pathogens such as that causing COVID-19. This project will develop a new process that can be rapidly